Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony W Tolcher, M.D.
START (South Texas Accelerated Research Therapeutics)
Principal Investigator - Antoni Ribas, M.D.
UCLA Jonsson Comprehensive Cancer Center
Principal Investigator - Yun Yen, M.D., Ph.D.
City of Hope National Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
- Ucla Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Start (south Texas Accelerated Research Therapeutics)
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2008
- Primary completion
- 30 Sept 2012
- Completion
- 30 Sept 2012
- Last update posted
- 1 Nov 2013
- Registered enrollment
- 24
- Registry id
- NCT00689065
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.